Fundraising Fox
Stuarttherapeutics
12 employees on LinkedIn · 1 known investors
Find your way into Stuarttherapeutics
Sign up to see every warm intro you have to Stuarttherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stuarttherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix. Its therapies target chronic eye diseases including dry eye disease, glaucoma, and inherited retinal disorders such as retinitis pigmentosa and age-related macular degeneration.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Stuarttherapeutics do?
- Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix. Its therapies target chronic eye diseases including dry eye disease, glaucoma, and inherited retinal disorders such as retinitis pigmentosa and age-related macular degeneration.
- Who founded Stuarttherapeutics?
- Stuarttherapeutics was founded by Robert O. Baratta.
- Who are Stuarttherapeutics's investors?
- Stuarttherapeutics's investors include BioBrit.